Actively Recruiting
TARGET-ASPECT Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
Led by Centre Hospitalier de Gonesse · Updated on 2025-07-16
152
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating patients who have experienced acute ischemic stroke and were treated with clot-busting medicine (thrombolysis) and a procedure to remove the clot (thrombectomy). Despite these treatments, about half of patients do not fully recover. The study aims to determine if certain brain imaging scores, alone or combined, can better predict patient recovery 90 days after stroke and the success of blood vessel reopening. This observational study will include 152 patients and is sponsored by Centre Hospitalier de Gonesse. The study involves observing patients who received both thrombolysis and thrombectomy after an acute ischemic stroke. There are no additional treatments or interventions given as part of the study. Instead, the researchers will analyze brain imaging and clinical data collected during routine care to assess how well the imaging scores predict recovery outcomes. Participants will be followed for about 90 days after their stroke. Researchers will collect clinical follow-up data, including the modified Rankin Scale (mRS) score at 90 days, to measure recovery. The main outcome is a favorable functional outcome defined as an mRS score of 0 to 2 at 90 days. The study aims to find simple and reliable tools to help doctors make better treatment decisions in the future.
CONDITIONS
Brief Title
Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Confirmed acute ischemic stroke on imaging
- Treated with both thrombolysis and thrombectomy
- Clinical follow-up data available at 90 days (mRS score)
You will not qualify if you...
- Primary hemorrhagic stroke
- Early death or loss to follow-up without evaluation
- Poor-quality imaging that cannot be analyzed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 90 days
Participants are observed after treatment to assess functional outcomes at 90 days.
1 follow-up visit at 90 days
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de Gonesse
Gonesse, France
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here